Clauss Heather E, Bettiker Robert L, Samuel Rafik, Truant Allan L, Jungkind Donald, Suh Byungse
Section of Infectious Diseases, Temple University School of Medicine, Philadelphia, Pennsylvania.
Clinical Microbiology, Immunology, and Virology Laboratories, Department of Pathology and Laboratory Medicine, Temple University Hospital and School of Medicine, Philadelphia, Pennsylvania.
Clin Microbiol Newsl. 2012 Feb 1;34(3):19-25. doi: 10.1016/j.clinmicnews.2012.01.001. Epub 2012 Jan 17.
Patients undergoing thoracic organ transplantation procedures involving the heart or lung are at increased risk for developing a wide variety of infections due to their underlying immunosuppression and/or other factors. Lung transplant recipients are at high risk for developing infections caused by bacteria, viruses, and opportunistic fungi, whereas heart transplant recipients are at risk for developing infections caused by these same microorganisms, as well as parasitic infections, including toxoplasmosis and New World trypanosomiasis. This review will highlight the various infections that thoracic organ transplant recipients may develop following their procedures.
接受涉及心脏或肺部的胸器官移植手术的患者，由于其潜在的免疫抑制和/或其他因素，发生各种感染的风险增加。肺移植受者发生由细菌、病毒和机会性真菌引起的感染的风险很高，而心脏移植受者发生由这些相同微生物引起的感染以及寄生虫感染（包括弓形虫病和美洲锥虫病）的风险很高。本综述将重点介绍胸器官移植受者术后可能发生的各种感染。
